Telehealth & Digital Health

Beyond amyloid plaques, a new therapy tackles Alzheimer's by reducing inflammation. Longeveron's latest data offers a glimpse into a regenerative future.

New real-time imaging gives surgeons a 3D molecular map of cancer in the OR, poised to end the emotional and physical toll of reoperations for many.

A deal between a Korean innovator and a Baxter subsidiary is set to replace the surgical microscope, promising better ergonomics and a future of AI-guided surgery.

For years, CIDP patients faced limited options. Now, a wave of targeted therapies promises to transform treatment, sparking a multi-billion dollar market boom.

A silent health crisis affecting a billion women is becoming a major economic focus. One firm's move to train a new workforce signals a paradigm shift.

With $4.6M in funding, a San Diego startup is challenging the multi-million dollar surgical robotics market with a handheld, AI-powered device.

The Senate's new Naloxone Awareness Day highlights a critical shift. As fentanyl rages, a life-saving drug is moving from ambulances to school hallways.

Nuwellis bets on educating hundreds of physicians on its Aquadex system, a high-stakes strategy to combat fluid overload and secure its place in medicine.

A health AI company is adding top cardiologists to its board, signaling a strategic shift to prove that algorithms can solve real-world health crises.

R1's new Phare OS intelligence engine promises to upend the slow, costly cycle of medical claims. Can real-time adjudication finally fix a broken system?

BioCardia bets its future on Japan's fast-track approval for its heart therapy, a strategic pivot that could unlock global markets or break the bank.

A new drug from Cambrian Bio shows promise in activating a key metabolic switch. This could lead to treatments that burn fat while preserving muscle mass.

A new firm, Nortiva Bio, is launching with tech from MIT to turn daily pills into monthly doses, starting with a contraceptive backed by the Gates Foundation.

Beyond the ribbon-cutting, Healthconnect Texas's new hub is the physical anchor for an ambitious plan to merge clinical and social data, reshaping care for 27M.

With a fresh $50M, Enhanced Group is selling a future of medically-guided peak performance. But can its controversial Games and peptide platform survive regulatory scrutiny?

A new spray-dried plasma could end reliance on freezers, transforming trauma care from the battlefield to rural ERs. But can Velico navigate the path to market?

A 'dream team' of pharma veterans has raised $180M to advance a next-gen oral drug, promising to transform the multi-billion dollar IBD market.

Memo Therapeutics' Potravitug shows promise in a Phase II trial, offering the first real weapon against a common virus that threatens kidney transplants.

Dr. Glenn Parker's recent award is more than a trophy. It's a signal of a quiet revolution in healthcare—one that uses fintech to build national resilience.

Merck secures a pivotal FDA approval for its CAPVAXIVE vaccine, offering new hope for at-risk youth and challenging rivals in the high-stakes pneumococcal market.